Three-dimensional system enabling the maintenance and directed differentiation of pluripotent stem cells under defined conditions

A three-dimensional culture system enables maintenance of pluripotent stem cells (PSCs) and formation of PSC-derived organoids. The development of in vitro models for the maintenance and differentiation of pluripotent stem cells (PSCs) is an active area of stem cell research. The strategies used so far are based mainly on two-dimensional (2D) cultures, in which cellular phenotypes are regulated by soluble factors. We show that a 3D culture system with atelocollagen porous scaffolds can significantly improve the outcome of the current platforms intended for the maintenance and lineage specification of mouse PSCs (mPSCs). Unlike 2D conditions, the 3D conditions maintained the undifferentiated state of mouse embryonic stem cells (mESCs) without exogenous stimulation and also supported endoderm, mesoderm, and ectoderm differentiation of mESCs under serum-free conditions. Moreover, 3D mPSC–derived mesodermal cells showed accelerated osteogenic differentiation, giving rise to functional osteoblast-osteocyte populations within calcified structures. The present strategy offers a 3D platform suitable for the formation of organoids that mimic in vivo organs containing various cell types, and it may be adaptable to the generation of ectoderm-, mesoderm-, and endoderm-derived tissues when combined with appropriate differentiation treatments.

[1]  T. Takato,et al.  Gli1 Protein Participates in Hedgehog-mediated Specification of Osteoblast Lineage during Endochondral Ossification* , 2012, The Journal of Biological Chemistry.

[2]  D. Santosa,et al.  Mimicking cell-cell interactions at the biomaterial-cell interface for control of stem cell differentiation. , 2006, Journal of biomedical materials research. Part A.

[3]  S. Varghese,et al.  Small molecule–driven direct conversion of human pluripotent stem cells into functional osteoblasts , 2016, Science Advances.

[4]  B. Heng,et al.  Comparison of osteogenesis of human embryonic stem cells within 2D and 3D culture systems , 2008, Scandinavian journal of clinical and laboratory investigation.

[5]  T. Hefferan,et al.  Collagen type I hydrogel allows migration, proliferation, and osteogenic differentiation of rat bone marrow stromal cells. , 2010, Journal of biomedical materials research. Part A.

[6]  M. Gassmann,et al.  Differentiating embryonic stem cells into embryoid bodies. , 2004, Methods in molecular biology.

[7]  B. Teicher,et al.  Tumor resistance to alkylating agents conferred by mechanisms operative only in vivo. , 1990, Science.

[8]  T. Martin,et al.  Osteoblastic cells are involved in osteoclast formation. , 1988, Endocrinology.

[9]  V. Sikavitsas,et al.  Enhanced osteoblastic differentiation of mesenchymal stem cells seeded in RGD‐functionalized PLLA scaffolds and cultured in a flow perfusion bioreactor , 2011, Journal of tissue engineering and regenerative medicine.

[10]  Antonios G Mikos,et al.  Modulation of cell differentiation in bone tissue engineering constructs cultured in a bioreactor. , 2006, Advances in experimental medicine and biology.

[11]  D. Rowe,et al.  Upstream regulatory elements necessary for expression of the rat COL1A1 promoter in transgenic mice , 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[12]  K. Shakesheff,et al.  Osteogenic differentiation of embryonic stem cells in 2D and 3D culture. , 2011, Methods in molecular biology.

[13]  Jin Han,et al.  The importance of three-dimensional scaffold structure on stemness maintenance of mouse embryonic stem cells. , 2014, Biomaterials.

[14]  P. Hulley,et al.  Enhanced osteoblastogenesis in three-dimensional collagen gels. , 2014, BoneKEy reports.

[15]  Roberto Osellame,et al.  Two-photon polymerized “nichoid” substrates maintain function of pluripotent stem cells when expanded under feeder-free conditions , 2016, Stem Cell Research & Therapy.

[16]  D. Rowe,et al.  Use of Type I Collagen Green Fluorescent Protein Transgenes to Identify Subpopulations of Cells at Different Stages of the Osteoblast Lineage , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[17]  J. Hubbell,et al.  Long-term maintenance of mouse embryonic stem cell pluripotency by manipulating integrin signaling within 3D scaffolds without active Stat3. , 2012, Biomaterials.

[18]  H. Nakauchi,et al.  Stepwise Differentiation of Pluripotent Stem Cells into Osteoblasts Using Four Small Molecules under Serum-free and Feeder-free Conditions , 2014, Stem cell reports.

[19]  Jennifer Nichols,et al.  The Transcriptional and Epigenomic Foundations of Ground State Pluripotency , 2012, Cell.

[20]  E. Cho,et al.  Smad4 controls bone homeostasis through regulation of osteoblast/osteocyte viability , 2016, Experimental & Molecular Medicine.

[21]  John K. Heath,et al.  Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides , 1988, Nature.

[22]  Antonios G. Mikos,et al.  Fluid flow increases mineralized matrix deposition in 3D perfusion culture of marrow stromal osteoblasts in a dose-dependent manner , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[23]  S. Donahue,et al.  Mechanical stimulation of MC3T3 osteoblastic cells in a bone tissue-engineering bioreactor enhances prostaglandin E2 release. , 2005, Tissue engineering.

[24]  P. Serup,et al.  Retinoic Acid Synthesis Promotes Development of Neural Progenitors from Mouse Embryonic Stem Cells by Suppressing Endogenous, Wnt‐Dependent Nodal Signaling , 2010, Stem cells.

[25]  Jiahong Dong,et al.  Stem cells in a three-dimensional scaffold environment , 2014, SpringerPlus.

[26]  Adrian Ranga,et al.  Defined three-dimensional microenvironments boost induction of pluripotency. , 2016, Nature materials.

[27]  H. Ohgushi,et al.  In vitro osteogenic differentiation of HOS cells on two types of collagen gels. , 2010, Journal of bioscience and bioengineering.

[28]  Kosaku Kurata,et al.  Evidence for osteocyte regulation of bone homeostasis through RANKL expression , 2011, Nature Medicine.

[29]  J. Elisseeff,et al.  Human iPSC-derived osteoblasts and osteoclasts together promote bone regeneration in 3D biomaterials , 2016, Scientific Reports.

[30]  Donald Metcalf,et al.  Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells , 1988, Nature.

[31]  D. Jiang,et al.  Study of bone-like hydroxyapatite/polyamino acid composite materials for their biological properties and effects on the reconstruction of long bone defects , 2015, Drug design, development and therapy.

[32]  N. Mustapha,et al.  Cockle Shell-Based Biocomposite Scaffold for Bone Tissue Engineering , 2011 .

[33]  J. Davies,et al.  Engineering three-dimensional bone tissue in vitro using biodegradable scaffolds: investigating initial cell-seeding density and culture period. , 2000, Journal of biomedical materials research.

[34]  W. Mutschler,et al.  Hypoxia in static and dynamic 3D culture systems for tissue engineering of bone. , 2008, Tissue engineering. Part A.

[35]  R. Misra,et al.  The synergistic effect of a hybrid graphene oxide-chitosan system and biomimetic mineralization on osteoblast functions. , 2014, Biomaterials science.

[36]  Jinhu Xiong,et al.  Matrix-embedded cells control osteoclast formation , 2011, Nature Medicine.

[37]  Robert E Guldberg,et al.  Effects of medium perfusion rate on cell-seeded three-dimensional bone constructs in vitro. , 2003, Tissue engineering.

[38]  E. Stanley,et al.  Retinoic acid induces Pdx1-positive endoderm in differentiating mouse embryonic stem cells. , 2005, Diabetes.

[39]  K. No,et al.  CXXC5 is a negative-feedback regulator of the Wnt/β-catenin pathway involved in osteoblast differentiation , 2015, Cell Death and Differentiation.

[40]  Sheng Ding,et al.  Small molecules that modulate embryonic stem cell fate and somatic cell reprogramming. , 2010, Trends in pharmacological sciences.

[41]  R. Schugar,et al.  Small molecules in stem cell self-renewal and differentiation , 2008, Gene Therapy.

[42]  B. Doble,et al.  The ground state of embryonic stem cell self-renewal , 2008, Nature.

[43]  Robert Langer,et al.  Three-dimensional biomaterials for the study of human pluripotent stem cells , 2011, Nature Methods.

[44]  A. Bender,et al.  Systematic selection of small molecules to promote differentiation of embryonic stem cells and experimental validation for generating cardiomyocytes , 2016, Cell Death Discovery.

[45]  Kozo Nakamura,et al.  Identification of a potent combination of osteogenic genes for bone regeneration using embryonic stem (ES) cell‐based sensor , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[46]  Paolo Zunino,et al.  Distributed and Lumped Parameter Models for the Characterization of High Throughput Bioreactors , 2016, PloS one.

[47]  D. Roop,et al.  Osteoblasts Derived from Induced Pluripotent Stem Cells form Calcified Structures in Scaffolds Both In Vitro and In Vivo , 2011, Stem cells.

[48]  E. Stanley,et al.  Retinoic Acid Induces Pdx 1-Positive Endoderm in Differentiating Mouse Embryonic Stem Cells , 2005 .

[49]  P. Schultz,et al.  A role for chemistry in stem cell biology , 2004, Nature Biotechnology.

[50]  Kozo Nakamura,et al.  Patched1 haploinsufficiency increases adult bone mass and modulates Gli3 repressor activity. , 2008, Developmental cell.